Investment Managers Pvt. Ltd. announced the launch of DSP Healthcare Fund, an open ended scheme investing in the healthcare and pharma sector. The fund would be predominantly investing in equity and equity related securities of healthcare and pharmaceutical companies with some portfolio allocation to foreign securities. The NFO is scheduled to open on November 12 and close on November 26, 2018.
Announcing the launch of the new fund, Kalpen Parekh, President, DSP Investment Managers said, “This is an interesting time for the Indian Healthcare sector. Despite disappointing earnings growth in FY18, many companies are at an inflection point and have the potential to be re-rated as temporary disruptions get resolved. Indian investors can take advantage of the potential in the space with an added element of global diversification to manage volatility. I am confident that Aditya’s global sector experience and Vinit’s expertise in healthcare and small and mid-caps can be significant advantages in identifying and leveraging the potential in the space.”
Vinit Sambre, Head – Equities, DSP Investment Managers said, “India is expected to be part of the top three pharmaceutical markets in terms of consumption by 2030. Many of these Indian healthcare companies have a good long-term potential as they are focusing on R&D and are reducing their overheads with the results likely to reflect in their profitability over time. Government measures like Ayushman Bharat as part of a conducive policy are also expected to spur growth in the sector. Investors can also look to benefit from international healthcare exposure which may help in reducing portfolio volatility and could also help deliver better returns per unit of risk.”
